Most cited papers from Pharmerit (Netherlands)

Pharmerit (Netherlands)

What are the most cited papers from Pharmerit (Netherlands)?

The most cited paper from Pharmerit (Netherlands) is "Surgical vs Nonsurgical Treatment of Adults With Displaced Fractures of the Proximal Humerus" (Amar Rangan, Helen HG Handoll, Stephen Brealey et al., 2015), with 553 citations. Next come "A Systematic Review of Medical Costs Associated with Heart Failure in the USA (2014–2020)" (407) and "Humanistic and economic burden of painful diabetic peripheral neuropathy in Europe: A review of the literature" (234).

Published TypeFieldAccessCitations

Showing 50 of 62 papers. Every paper with more than 19 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Surgical vs Nonsurgical Treatment of Adults With Displaced Fractures of the Proximal Humerus Amar Rangan, Helen HG Handoll, Stephen Brealey et al. · JAMA	10 Mar 2015	553
2	A Systematic Review of Medical Costs Associated with Heart Failure in the USA (2014–2020) Michael Urbich, Gary A. Globe, Krystallia Pantiri et al. · PharmacoEconomics ReviewOpen access	19 Aug 2020	407
3	Humanistic and economic burden of painful diabetic peripheral neuropathy in Europe: A review of the literature Cathelijne Alleman, Kirsten Y Westerhout, Marja Hensen et al. · Diabetes Research and Clinical Practice Open access	5 May 2015	234
4	A simulation study of sample size demonstrated the importance of the number of events per variable to develop prediction models in clustered data Laure Wynants, Walter Bouwmeester, Karel G.M. Moons et al. · Journal of Clinical Epidemiology Open access	13 Feb 2015	175
5	The ProFHER (PROximal Fracture of the Humerus: Evaluation by Randomisation) trial – a pragmatic multicentre randomised controlled trial evaluating the clinical effectiveness and cost-effectiveness of surgical compared with non-surgical treatment for proximal fracture of the humerus in adults Helen HG Handoll, Stephen Brealey, Amar Rangan et al. · Health Technology Assessment Open access	Mar 2015	147
6	Anti-vascular endothelial growth factor in neovascular age-related macular degeneration – a systematic review of the impact of anti-VEGF on patient outcomes and healthcare systems Robert Patrick Finger, Vincent Daïen, Bora M. Eldem et al. · BMC Ophthalmology ReviewOpen access	17 Jul 2020	143
7	Capsaicin 8% Patch Versus Oral Neuropathic Pain Medications for the Treatment of Painful Diabetic Peripheral Neuropathy: A Systematic Literature Review and Network Meta-analysis Floortje E. van Nooten, M. Treur, Krystallia Pantiri et al. · Clinical Therapeutics ReviewOpen access	30 Mar 2017	117
8	The economic burden of bronchiectasis – known and unknown: a systematic review Pieter Goeminne, Francisco Hernandez, Roland Diel et al. · BMC Pulmonary Medicine ReviewOpen access	28 Feb 2019	96
9	Relationship between the Asthma Control Test (ACT) and other outcomes: a targeted literature review Bas C. P. van Dijk, Henrik Svedsäter, Andreas Heddini et al. · BMC Pulmonary Medicine Open access	3 Apr 2020	93
10	Clinical Effectiveness of Liraglutide in Type 2 Diabetes Treatment in the Real-World Setting: A Systematic Literature Review Amrita Ostawal, Emina Mocevic, Nana Kragh et al. · Diabetes Therapy ReviewOpen access	27 Jun 2016	86
11	Measurement of adherence to BCR-ABL inhibitor therapy in chronic myeloid leukemia: current situation and future challenges Lucien A. Noens, M. Hensen, I. Kucmin-Bemelmans et al. · Haematologica Open access	Mar 2014	83
12	Health-related quality of life and mortality in patients with pulmonary embolism: a prospective cohort study in seven European countries Ling‐Hsiang Chuang, Pearl D Gumbs, Ben van Hout et al. · Quality of Life Research Open access	4 Apr 2019	65
13	Costs and effects of long-acting risperidone compared with oral atypical and conventional depot formulations in Germany Gerd Laux, Bart M. S. Heeg, Ben A. van Hout et al. · PharmacoEconomics	Dec 2005	65
14	Health State Utilities of Patients with Heart Failure: A Systematic Literature Review Gian Luca Di Tanna, Michael Urbich, Heidi S. Wirtz et al. · PharmacoEconomics ReviewOpen access	30 Nov 2020	58
15	Economic burden associated with acute myeloid leukemia treatment Amer Methqal Zeidan, Dalia Mahmoud, I. Kucmin-Bemelmans et al. · Expert Review of Hematology	14 Nov 2015	58
16	Measuring the Benefits of Healthcare: DALYs and QALYs – Does the Choice of Measure Matter? A Case Study of Two Preventive Interventions Federico Augustovski, Lisandro Damián Colantonio, Julieta Galante et al. · International Journal of Health Policy and Management Open access	6 Jan 2017	56
17	Comparative efficacy, safety and durability of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: an update on a systematic review and network meta-analysis Katharina Nickel, Nicholas James Anthony Halfpenny, Sonya J. Snedecor et al. · BMC Infectious Diseases ReviewOpen access	26 Feb 2021	53
18	Deep Vein Thrombosis in Europe—Health-Related Quality of Life and Mortality Manuel Monréal, Giancarlo Agnelli, Ling‐Hsiang Chuang et al. · Clinical and Applied Thrombosis/Hemostasis Open access	2019	53
19	Real‐world treatment patterns and outcomes using terlipressin in 203 patients with the hepatorenal syndrome Kevin Moore, Khurram Jamil, Katharina Verleger et al. · Alimentary Pharmacology & Therapeutics Open access	4 Jun 2020	50
20	Patient-reported outcomes in head and neck and thyroid cancer randomised controlled trials: A systematic review of completeness of reporting and impact on interpretation Rebecca Mercieca‐Bebber, Alessandro Perreca, Madeleine Trudy King et al. · European Journal of Cancer Review	4 Feb 2016	50
21	Cost effectiveness analysis of immunotherapy in patients with grass pollen allergic rhinoconjunctivitis in Germany K.Y. Westerhout, Bram G. Verheggen, C.H. Schreder et al. · Journal of Medical Economics	26 Apr 2012	48
22	Pharmacokinetic-Pharmacodynamic Model for the Reversal of Neuromuscular Blockade by Sugammadex Bart A. Ploeger, Jean M. W. Smeets, Ashley Strougo et al. · Anesthesiology	17 Dec 2008	48
23	Modelling Approaches Bart M. S. Heeg, Joep Damen, Erik Buskens et al. · PharmacoEconomics	2008	47
24	Self vs. other, child vs. adult. An experimental comparison of valuation perspectives for valuation of EQ-5D-Y-3L health states Stefan A. Lipman, Vivian Reckers‐Droog, Milad Karimi et al. · The European Journal of Health Economics Open access	6 Oct 2021	46
25	Comparative effectiveness of antibiotics for the treatment of MRSA complicated skin and soft tissue infections JFS Logman, Jennifer M.L. Stephens, Bart M. S. Heeg et al. · Current Medical Research and Opinion	30 Apr 2010	46
26	A new method for valuing health: directly eliciting personal utility functions Nancy J. Devlin, Koonal Kirit Shah, Brendan James Mulhern et al. · The European Journal of Health Economics Open access	20 Jul 2018	44
27	Modelling the treated course of schizophrenia: Development of a discrete event simulation model Bart M. S. Heeg, Erik Buskens, Martin Richard John Knapp et al. · PharmacoEconomics	Dec 2005	44
28	Methods applied in cost-effectiveness models for treatment strategies in type 2 diabetes mellitus and their use in Health Technology Assessments: a systematic review of the literature from 2008 to 2013 Mata Charokopou, FJ Sabater, R. Townsend et al. · Current Medical Research and Opinion ReviewOpen access	20 Oct 2015	43
29	Efficacy of recombinant activated factor VII vs. activated prothrombin complex concentrate for patients suffering from haemophilia complicated with inhibitors: a Bayesian meta‐regression M. Treur, Fiona B Mccracken, Bart M. S. Heeg et al. · Haemophilia	Mar 2009	42
30	Pulmonary embolism in Europe - Burden of illness in relationship to healthcare resource utilization and return to work Stefan N. Willich, Ling‐Hsiang Chuang, Ben van Hout et al. · Thrombosis Research Open access	16 Feb 2018	41
31	Cost-effectiveness of dapagliflozin versus DPP-4 inhibitors as an add-on to Metformin in the Treatment of Type 2 Diabetes Mellitus from a UK Healthcare System Perspective Mata Charokopou, Phil C. McEwan, Steven Lister et al. · BMC Health Services Research Open access	Jun 2015	41
32	Health economic comparison of SLIT allergen and SCIT allergoid immunotherapy in patients with seasonal grass‐allergic rhinoconjunctivitis in Germany Bram G. Verheggen, K.Y. Westerhout, C.H. Schreder et al. · Clinical and Translational Allergy Open access	2015	38
33	Cost effectiveness of surgical versus non-surgical treatment of adults with displaced fractures of the proximal humerus Belén Corbacho, Ana Duarte, Ada Keding et al. · The Bone & Joint Journal Open access	Feb 2016	37
34	The burden of atrial fibrillation in the Netherlands Henriette E. van Heemstra, Robby Nieuwlaat, M. Meijboom et al. · Netherlands Heart Journal Open access	14 Jul 2011	37
35	The cost‐effectiveness of dapagliflozin versus sulfonylurea as an add‐on to metformin in the treatment of Type 2 diabetes mellitus Mata Charokopou, Phil C. McEwan, Steven Lister et al. · Diabetic Medicine	29 Mar 2015	36
36	Measurement Properties of Commonly Used Generic Preference-Based Measures in East and South-East Asia: A Systematic Review Xinyu Qian, Rachel Lee-Yin Tan, Ling‐Hsiang Chuang et al. · PharmacoEconomics ReviewOpen access	25 Nov 2019	35
37	Which Factors Enhance Positive Drug Reimbursement Recommendation in Scotland? A Retrospective Analysis 2006–2013 Mata Charokopou, Istvan Matyas Majer, Johan de Raad et al. · Value in Health Open access	4 Feb 2015	35
38	Drug survival of second biological DMARD therapy in patients with rheumatoid arthritis: a retrospective non-interventional cohort analysis Thomas Wilke, S. Mueller, Sze Chim Lee et al. · BMC Musculoskeletal Disorders Open access	Aug 2017	33
39	Network meta-analysis of (individual patient) time to event data alongside (aggregate) count data Pedro Saramago, Ling‐Hsiang Chuang, Marta O. Soares · BMC Medical Research Methodology ReviewOpen access	10 Sep 2014	33
40	A pharmaco-economic analysis of patients with schizophrenia switching to generic risperidone involving a possible compliance loss M. Treur, Bart M. S. Heeg, Hans‐Jürgen Möller et al. · BMC Health Services Research Open access	18 Feb 2009	31
41	A need for implementation science to optimise the use of evidence-based interventions in HIV care: A systematic literature review Joseph Cox, Cassidy A. Gutner, Nadine Kronfli et al. · PLoS ONE ReviewOpen access	19 Aug 2019	30
42	Economic burden of inpatient and outpatient antibiotic treatment for methicillin-resistant Staphylococcus aureus complicated skin and soft-tissue infections: a comparison of linezolid, vancomycin, and daptomycin Dipen A. Patel, Jennifer M. L. Stephens, Xin Gao et al. · ClinicoEconomics and Outcomes Research Open access	Sep 2013	30
43	What Did Time Tell Us? A Comparison and Retrospective Validation of Different Survival Extrapolation Methods for Immuno-Oncologic Therapy in Advanced or Metastatic Renal Cell Carcinoma Sven L. Klijn, Elisabeth A. L. Fenwick, Sonja Kroep et al. · PharmacoEconomics	11 Jan 2021	28
44	Mortality Prediction of the CHA2DS2-VASc Score, the HAS-BLED Score, and Their Combination in Anticoagulated Patients with Atrial Fibrillation Doralisa Morrone, Sonja Kroep, Fabrizio Ricci et al. · Journal of Clinical Medicine Open access	9 Dec 2020	27
45	Assessment of the Economic Impact of Belimumab for the Treatment of Systemic Lupus Erythematosus in the Italian Setting: A Cost-Effectiveness Analysis F. Pierotti, Ilaria Palla, M. Treur et al. · PLoS ONE Open access	21 Oct 2015	27
46	Long-Term Clopidogrel Therapy in Patients Receiving Percutaneous Coronary Intervention Bart M. S. Heeg, Ron J.G. Peters, Marc F Botteman et al. · PharmacoEconomics	2007	25
47	A cost-effectiveness analysis of iStent inject combined with phacoemulsification cataract surgery in patients with mild-to-moderate open-angle glaucoma in France Kaspar Nieland, Antoine Labbé, Cédric Schweitzer et al. · PLoS ONE Open access	10 Jun 2021	24
48	Real-world Outcomes of Multiple Myeloma: Retrospective Analysis of the Czech Registry of Monoclonal Gammopathies Roman Hájek, Jiří Jarkovský, Vladimír Maisnar et al. · Clinical Lymphoma Myeloma & Leukemia	16 Apr 2018	24
49	The Cost-Effectiveness of Atypicals in the UK Bart M. S. Heeg, Erik Buskens, Marc F Botteman et al. · Value in Health Open access	16 May 2008	24
50	A Targeted Literature Review of the Disease Burden in Patients With Symptomatic Peripheral Artery Disease Rupert Martin Bauersachs, E. Sebastian Debus, Mark R. Nehler et al. · Angiology	30 Dec 2019	23

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.